-

KBRA Releases Research – Synthetic Risk Transfer Transactions: A Growing Bank Capital Tool

NEW YORK--(BUSINESS WIRE)--KBRA releases research that examines the capital relief that financial institutions can obtain using synthetic risk transfer (SRT) transactions, as well as typical structural features, market volumes, and recent developments regarding Basel 3 capital requirements. SRT transactions, a form of securitization, have gained prominence in optimizing capital requirements for financial institutions by reducing risk weightings assigned to portfolios of loans held on their balance sheet.

The SRT market has been expanding since 2014, with over 100 deals executed globally in 2022. Growth has occurred across various assets classes and geographies, including the U.S., since 2019. Further growth is anticipated in the years ahead given the implementation demands of Basel 3 Endgame for increased bank capital.

Click here for the report.

Related Publications

About KBRA

KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Doc ID: 1006102

Contacts

Killian Walsh, Managing Director
+353 1 588 1184
killian.walsh@kbra.com

Sharif Mahdavian, Managing Director
+1 646-731-2301
sharif.mahdavian@kbra.com

Gordon Kerr, Managing Director, Head of European Research
+44 20 8148 1020
gordon.kerr@kbra.com

Jack Kahan, Senior Managing Director, Head of Global RMBS
+1 646-731-2486
jack.kahan@kbra.com

Eric Neglia, Head of Commercial and Consumer ABS
+1 646-731-2456
eric.neglia@kbra.com

Business Development Contacts

Rosemary Kelley, Senior Managing Director, Head of Structured Finance and Project Finance
+1 646-731-2337
rosemary.kelley@kbra.com

Miten Amin, Managing Director
+44 20 8148 1002
miten.amin@kbra.com

Kroll Bond Rating Agency, LLC

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Killian Walsh, Managing Director
+353 1 588 1184
killian.walsh@kbra.com

Sharif Mahdavian, Managing Director
+1 646-731-2301
sharif.mahdavian@kbra.com

Gordon Kerr, Managing Director, Head of European Research
+44 20 8148 1020
gordon.kerr@kbra.com

Jack Kahan, Senior Managing Director, Head of Global RMBS
+1 646-731-2486
jack.kahan@kbra.com

Eric Neglia, Head of Commercial and Consumer ABS
+1 646-731-2456
eric.neglia@kbra.com

Business Development Contacts

Rosemary Kelley, Senior Managing Director, Head of Structured Finance and Project Finance
+1 646-731-2337
rosemary.kelley@kbra.com

Miten Amin, Managing Director
+44 20 8148 1002
miten.amin@kbra.com

Social Media Profiles
More News From Kroll Bond Rating Agency, LLC

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...

KBRA Assigns Preliminary Ratings to OBX 2026-NQM4 Trust

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 14 classes of mortgage-backed notes from OBX 2026-NQM4 Trust, a $789.6 million non-prime RMBS transaction. The underlying collateral, comprising 1,476 residential mortgages, is characterized by fixed-rate mortgages (FRMs) and hybrid adjustable-rate mortgages (ARMs) making up 92.3% and 7.7% of the pool, respectively. A majority of the loans are either classified as non-qualified mortgages (Non-QM; 37.0%) or exempt (51.6%) from the Ab...
Back to Newsroom